AVLN

NASDAQ Healthcare

Avalyn Pharma Inc. - common stock

Biotechnology

Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs. Its current pipeline is focused on treating pulmonary fibrosis. Its products include AP01 and AP02, inhaled formulations of pirfenidone and nintedanib for the treatment of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis; and AP03, a fixed-dose combination of inhaled pirfenidone and nintedanib to deliver dual antifibrotic mechanisms. Avalyn Pharma Inc. was formerly known as Genoa Pharmaceuticals, Inc. and changed its name to Avalyn Pharma Inc. in July 2017. The company was incorporated in 2011 and is based in Boston, Massachusetts.

�� 市场数据
价格$29.84
成交量829,777
市值1.25B
52周最高$30.20
52周最低$26.00
在Yahoo Finance查看 →
🎯 投资策略评分

AVLN 在各投资策略中的评分。分数越高，越符合该策略目标。

💰 Dividend Daddy 30/100
高股息率 + 低波动性
🚀 Moon Shot 13/100
高增长潜力（高贝塔 + 超卖）
🔪 Falling Knife 62/100
逆向投资（超卖 + 低于移动均线）
🎈 Over-Hyped 34/100
超买股票（潜在做空标的）
🐋 Institutional Whale 29/100
大盘、机构级别股票
🔍 策略解读

最佳匹配： 🔪 Falling Knife (62/100) — 此策略 逆向投资（超卖 + 低于移动均线）.

评分最低的策略： 🚀 Moon Shot (13/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →

📚 了解更多
本页指标
教育文章
网站资源
在文本中查找 AVLN in your text

粘贴任何文章、记录或帖子 — 工具将提取 AVLN 以及每一个其他隐藏的股票代码。

试试股票代码提取器 →

免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-05-01.